Cargando…

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination

Detalles Bibliográficos
Autores principales: Barbhaiya, Medha, Levine, Jonah M, Bykerk, Vivian P, Mandl, Lisa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651251/
https://www.ncbi.nlm.nih.gov/pubmed/34901886
http://dx.doi.org/10.1016/S2665-9913(21)00372-6
_version_ 1784611363978477568
author Barbhaiya, Medha
Levine, Jonah M
Bykerk, Vivian P
Mandl, Lisa A
author_facet Barbhaiya, Medha
Levine, Jonah M
Bykerk, Vivian P
Mandl, Lisa A
author_sort Barbhaiya, Medha
collection PubMed
description
format Online
Article
Text
id pubmed-8651251
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86512512021-12-08 Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination Barbhaiya, Medha Levine, Jonah M Bykerk, Vivian P Mandl, Lisa A Lancet Rheumatol Comment Elsevier Ltd. 2022-02 2021-12-08 /pmc/articles/PMC8651251/ /pubmed/34901886 http://dx.doi.org/10.1016/S2665-9913(21)00372-6 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Barbhaiya, Medha
Levine, Jonah M
Bykerk, Vivian P
Mandl, Lisa A
Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
title Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
title_full Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
title_fullStr Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
title_full_unstemmed Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
title_short Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
title_sort immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of covid-19 vaccination
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651251/
https://www.ncbi.nlm.nih.gov/pubmed/34901886
http://dx.doi.org/10.1016/S2665-9913(21)00372-6
work_keys_str_mv AT barbhaiyamedha immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination
AT levinejonahm immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination
AT bykerkvivianp immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination
AT mandllisaa immunomodulatoryandimmunosuppressivemedicationmodificationamongpatientswithrheumaticdiseasesatthetimeofcovid19vaccination